A Phase 1 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (BRAINSTORM)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Jul 2017
At a glance
- Drugs RRx 001 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Acronyms BRAINSTORM
- Sponsors EpicentRx
- 02 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Apr 2016 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017 as reported by ClinicalTrials.gov record.
- 06 Apr 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017 as reported by ClinicalTrials.gov record.